V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20213010 | 20079535 | 1.66 | 73.4 | 01 | 2018-04-09 | 2018-05-07 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100681623 |
| 20213011 | 20079536 | 1.78 | 89.3 | Palliative (P) | 2017-09-18 | 2017-09-26 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 101383521 |
| 20213012 | 20079537 | 1.51 | 54 | Curative (C) | 2018-06-11 | 2018-07-01 | CISPLATIN + FLUOROURACIL | 02 | Y | CISPLATIN + FLUOROURACIL | 101747651 |
| 20213013 | 20079538 | 1.87 | null | Neo-adjuvant (N) | 2019-12-11 | 2020-01-01 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101366730 |
| 20213016 | 20079539 | 1.84 | 87.1 | Curative (C) | 2018-05-05 | 2018-06-02 | Doxorubicin chemoembolisation | 99 | N | DOXORUBICIN EMBOLISATION | 101422492 |
| 20213019 | 20079540 | null | null | Curative (C) | 2018-03-21 | 2018-03-25 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 101537407 |
| 20213020 | 20079541 | 1.8 | null | Palliative (P) | 2019-06-26 | 2019-07-11 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 101342806 |
| 20213021 | 20079542 | 1.85 | 124.4 | Palliative (P) | 2018-11-05 | 2018-11-12 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100668905 |
| 20213022 | 20079543 | 1.88 | 46 | Neo-adjuvant (N) | 2019-02-27 | 2019-03-04 | Capecitabine (14 days)+Carboplatin | N | N | CISPLATIN + FLUOROURACIL | 100835835 |
| 20213023 | 20079544 | 1.71 | 90.4 | Neo-adjuvant (N) | 2019-04-04 | 2019-04-09 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 101298531 |
| 20213024 | 20079545 | 0 | 39.8 | Neo-adjuvant (N) | 2019-01-07 | 2019-01-14 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 101152468 |
| 20213027 | 20079546 | 1.71 | 72.9 | Palliative (P) | 2018-05-17 | 2018-06-12 | Cisplatin +Fluorouracil (3 wk) | 2 | N | CISPLATIN + FLUOROURACIL | 101562539 |
| 20213028 | 20079547 | null | null | Neo-adjuvant (N) | 2016-03-05 | 2016-03-12 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100431228 |
| 20213031 | 20079548 | 0 | 0 | Neo-adjuvant (N) | 2017-08-09 | 2017-08-23 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 101243785 |
| 20213032 | 20079549 | 0 | 0 | Palliative (P) | 2020-12-22 | 2020-12-26 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100831920 |
| 20213033 | 20079550 | 1.57 | 78 | Neo-adjuvant (N) | 2019-10-23 | 2019-10-24 | Capecitabine (21days) + Carboplatin | 2 | N | TRIAL UNSPECIFIED | 100294929 |
| 20213035 | 20079551 | 1.7 | 64.4 | Palliative (P) | 2019-10-11 | 2019-10-17 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101575595 |
| 20213036 | 20079552 | 1.54 | 105 | null | 2017-12-02 | 2017-12-02 | CAPECITABINE + CARBOPLATIN | 02 | N | TRIAL UNSPECIFIED | 100729520 |
| 20213038 | 20079553 | 1.7 | 69 | Neo-adjuvant (N) | 2017-07-10 | 2017-07-12 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100552021 |
| 20213039 | 20079554 | 1.5 | 75.4 | Palliative (P) | 2018-01-18 | 2018-01-18 | Cisplatin + Fluorouracil + RT 5day | 02 | N | CISPLATIN + FLUOROURACIL | 101150775 |
| 20213040 | 20079555 | 1.67 | 105.6 | Adjuvant (A) | 2019-03-14 | 2019-03-28 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 101534492 |
| 20213042 | 20079556 | 1.64 | 75.1 | Palliative (P) | 2017-05-05 | 2017-05-05 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100187262 |
| 20213045 | 20079557 | 1.7 | 74 | Palliative (P) | 2020-08-11 | 2020-08-28 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100417278 |
| 20213046 | 20079558 | 1.68 | 83.3 | Curative (C) | 2016-06-10 | 2016-06-20 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 100763023 |
| 20213047 | 20079559 | 1.76 | 53.5 | Neo-adjuvant (N) | 2018-10-03 | 2018-10-03 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 101765309 |
| 20213048 | 20079560 | 1.74 | 82.5 | Palliative (P) | 2018-05-28 | 2018-05-28 | CISPLATIN + FLUOROURACIL | N | N | CISPLATIN + FLUOROURACIL | 101210351 |
| 20213049 | 20079561 | 1.47 | 72 | null | 2018-09-19 | 2018-09-22 | CAPECITABINE + CARBOPLATIN | 02 | null | CAPECITABINE + CARBOPLATIN | 100684362 |
| 20213050 | 20079562 | null | 61.4 | Neo-adjuvant (N) | 2022-02-01 | 2022-02-08 | Doxorubicin chemoembolisation | 02 | null | DOXORUBICIN EMBOLISATION | 100618857 |
| 20213051 | 20079563 | 1.69 | 76 | Neo-adjuvant (N) | 2020-02-14 | 2020-02-27 | CAPECITABINE + CARBOPLATIN | 02 | null | CAPECITABINE + CARBOPLATIN | 101484682 |
| 20213053 | 20079564 | 0 | 0 | Neo-adjuvant (N) | 2018-07-30 | 2018-08-18 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100201798 |
| 20213054 | 20079565 | 1.65 | 84.3 | Neo-adjuvant (N) | 2018-03-01 | 2018-03-10 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 100434979 |
| 20213056 | 20079566 | 1.82 | 86 | 03 | 2020-06-06 | 2020-06-09 | Trial Unspecified | 02 | null | TRIAL UNSPECIFIED | 100415647 |
| 20213057 | 20079567 | 1.72 | 74.6 | Curative (C) | 2016-11-17 | 2016-12-19 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100676880 |
| 20213058 | 20079568 | 1.73 | 68.7 | Curative (C) | 2018-07-17 | 2018-07-26 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101418238 |
| 20213059 | 20079569 | 1.73 | 57.05 | Palliative (P) | 2017-11-13 | 2017-11-20 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100051753 |
| 20213060 | 20079570 | 1.8 | 74 | null | 2018-10-15 | 2018-11-05 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101762626 |
| 20213061 | 20079571 | 1.72 | 69 | Neo-adjuvant (N) | 2019-01-15 | 2019-01-26 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 100020423 |
| 20213063 | 20079572 | 1.79 | 90.7 | Palliative (P) | 2021-04-05 | 2021-04-12 | CISPLATIN + FLUOROURACIL | 02 | null | CISPLATIN + FLUOROURACIL | 100186456 |
| 20213064 | 20079573 | 1.58 | 54 | null | 2017-10-17 | 2017-10-17 | CAPECITABINE + CARBOPLATIN | 02 | null | CAPECITABINE + CARBOPLATIN | 100429030 |
| 20213066 | 20079574 | 1.75 | 67.8 | Curative (C) | 2017-02-23 | 2017-03-06 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 100010651 |
| 20213067 | 20079575 | 1.7 | 90.6 | 03 | 2016-07-07 | 2016-07-22 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101154886 |
| 20213068 | 20079576 | 0 | 0 | 03 | 2018-09-30 | 2018-09-30 | Doxorubicin chemoembolisation | N | N | DOXORUBICIN EMBOLISATION | 101737597 |
| 20213069 | 20079577 | 1.78 | 49 | Neo-adjuvant (N) | 2016-11-01 | 2016-11-10 | CISPLATIN + FLUOROURACIL | N | Y | CISPLATIN + FLUOROURACIL | 100220992 |
| 20213070 | 20079578 | 1.66 | 73.9 | Curative (C) | 2017-07-24 | 2017-07-24 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101683804 |
| 20213071 | 20079579 | 0 | 0 | Palliative (P) | 2020-01-17 | 2020-01-23 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 101336146 |
| 20213072 | 20079580 | 0 | 0 | Neo-adjuvant (N) | 2019-07-04 | 2019-07-15 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 101123046 |
| 20213073 | 20079581 | 1.57 | null | Palliative (P) | 2018-09-21 | 2018-09-30 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 100558066 |
| 20213074 | 20079582 | 1.71 | 64.4 | Palliative (P) | 2016-11-27 | 2016-12-03 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100519227 |
| 20213075 | 20079583 | 1.57 | 69.6 | Palliative (P) | null | 2016-07-02 | Cisplatin +Fluorouracil (2 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 101135422 |
| 20213076 | 20079584 | 1.9 | 80 | Neo-adjuvant (N) | 2018-12-30 | 2018-12-30 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100088508 |